In this issue:
Patient detection vs. screening for melanoma
AD increases cataract risk
NMSC post-treatment recurrence rates
Vemurafenib improves survival in melanoma with BRAF
V600E mutation
Targeting KIT in metastatic melanoma
Post-treatment recurrence is common in del
Please login below to download this issue (PDF)